TherapeuticsMD Inc. | Ownership
Companies that own TherapeuticsMD Inc.
T. Rowe Price Associates, Inc.
23,404,309
10.81%
6,391,912
0.02%
06/30/2018
BNY Mellon Asset Management North America Corp.
18,275,125
8.44%
-1,736,168
0.06%
06/30/2018
BlackRock Fund Advisors
13,598,337
6.28%
459,156
0%
06/30/2018
JPMorgan Investment Management, Inc.
11,692,951
5.4%
812,434
0.02%
06/30/2018
The Vanguard Group, Inc.
11,396,141
5.26%
320,842
0%
06/30/2018
Franklin Advisers, Inc.
10,468,542
4.83%
-22,982
0.05%
06/30/2018
The Dreyfus Corp.
9,532,351
4.4%
14,623
0.14%
06/30/2018
Fidelity Management & Research Co.
9,485,301
4.38%
-8,958,539
0.01%
06/30/2018
JPMorgan Asset Management (UK) Ltd.
6,314,694
2.92%
-419,805
0.04%
06/30/2018
Voya Investment Management Co. LLC
3,419,174
1.58%
242,995
0.04%
06/30/2018
| Address |
6800 Broken Sound Parkway NW
Boca Raton Florida 33487
United States
|
|
Employees
|
- |
| Website |
http://www.therapeuticsmd.com |
| Updated |
07/08/2019 |
| TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands. |
